Plasma and Cyro: What’s in the Bag? (Video)
Dr. Yazer talks about plasma and cryo and what is really in the bag (30 minutes).
Monitoring Hemostasis with the TEG® (Video)
Mike Miller from Haemonetics Corporation discusses hemostasis monitoring with the TEG (22 minutes).
Challenging the Processes of Cell Salvage (Video)
Christine Windisch discusses the process of cell salvage while challanging some of the core principles (17 minutes).
Economics of Blood Management (Video)
Janet farwell discusses the econimoics of blood management with the Hemobag (22 minutes).
Bleeding and Clot Vulnerability (Video)
Dr. Wegner discusses the dynamics of bleeding and clot vulnerability (23 minutes).
Autotransfusion in Autologous Blood Management (Video)
John Rivera discusses the role of autotransfusion in a successuful blood management program (24 minutes).
Does the RBC Storage Lesion Matter Clinically? (Video)
Dr. Yazer discusses the deleterious clinical effects of RBC storage (36 minutes).
Principles of Hemostasis in the Coumadin Clinic (Video)
Dr. Ferris discusses the principles of hemostasis in the coumadin clinic (21 minutes).
Modified Ultrafiltration Attenuates Pulmonary-Derived Inflammatory Mediators in Response to Cardiopulmonary Bypass
We evaluated pulmonary inflammation in piglets undergoing CPB followed by MUF.
Evaluation of the Quadrox-I Neonatal Oxygenator with an Integrated Arterial Filter
This study investigated the new QUADROX-i Neonatal Oxygenator (D-72145, Maquet, Hirrlingen, Germany) with an integrated arterial filter in terms of the hemodynamic properties and ability to clear GME in response to hypothermic versus normothermic conditions, open versus closed arterial filter purge line, and varying flow rates in a simulated CPB circuit identical to that of the clinical setting.
Storage Time of Allogeneic Red Blood Cells is Associated With Risk of Severe Postoperative Infection After Coronary Artery Bypass Grafting
We therefore examined the association between the age of transfused RBCs and development of severe postoperative infection following coronary artery bypass grafting (CABG) in a large population-based cohort study.
Comparing the Effects of 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 on Coagulation and Inflammatory Response When Used as Priming Solutions for Cardiopulmonary Bypass
This prospective, randomized and controlled trial compares the use of human albumin (HA) and hydroxyethyl starch (HES) 130/0.4 in the priming solution for a non-biocompatible cardiopulmonary bypass (CPB) circuit.